Search Results - "Stavchansky, Salomon"
-
1
Critical research gaps in electronic cigarette devices and nicotine aerosols
Published in International journal of pharmaceutics (25-01-2021)“…[Display omitted] Electronic cigarettes (e-cigs) are devices that aerosolize nicotine-containing liquids for delivery as an inhaled vapor. E-cigs are currently…”
Get full text
Journal Article -
2
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Published in Molecular pharmaceutics (12-01-2004)“…The purpose of this study is to provisionally classify, based on the Biopharmaceutics Classification System (BCS), drugs in immediate-release dosage forms that…”
Get full text
Journal Article -
3
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
Published in Pharmaceutical research (01-03-2008)“…We recommend that regulatory agencies add the extent of drug metabolism (i.e., ≥ 90% metabolized) as an alternate method in defining Class 1 marketed drugs…”
Get full text
Journal Article -
4
Structure–activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: Effects on heme oxygenase-1 induction and antioxidant activities
Published in European journal of pharmacology (10-06-2010)“…To determine the relationship between catechol ring modifications and the activity of caffeic acid phenethyl ester (CAPE) as a cytoprotective agent, six…”
Get full text
Journal Article -
5
Time Course Expression Analysis of 1[2-cyano-3,12- dioxooleana-1,9(11)-dien-28-oyl]imidazole Induction of Cytoprotection in Human Endothelial Cells
Published in Gene Regulation and Systems Biology (07-04-2017)“…1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), a synthetic derivative of oleanolic acid that exhibits antioxidant and anti-inflammatory…”
Get full text
Journal Article -
6
Cytoprotection of human endothelial cells from oxidant stress with CDDO derivatives: network analysis of genes responsible for cytoprotection
Published in Pharmacology (01-01-2015)“…To identify drugs that may reduce the impact of oxidant stress on cell viability. Human umbilical vein endothelial cells were treated with 200 nmol/l CDDO-Im…”
Get more information
Journal Article -
7
Drug eluting stents and beyond
Published in Current pharmaceutical design (01-07-2008)“…The present review discusses the mechanism of late stent thrombosis and its distinction from restenosis and summarizes the advisory note issued by FDA on the…”
Get more information
Journal Article -
8
Cytoprotection of human endothelial cells from menadione cytotoxicity by caffeic acid phenethyl ester: The role of heme oxygenase-1
Published in European journal of pharmacology (04-09-2008)“…Caffeic acid phenethyl ester (CAPE), derived from various plant sources, has been shown to ameliorate ischemia/reperfusion injury in vivo, and this has been…”
Get full text
Journal Article -
9
Link between drug absorption solubility and permeability measurements in Caco-2 cells
Published in Journal of pharmaceutical sciences (01-12-1998)“…The objective of this investigation was to establish a relationship between drug permeability and solubility in vitro and the extent of drug absorption in…”
Get more information
Journal Article -
10
Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats
Published in Biopharmaceutics & drug disposition (01-07-2009)“…The pharmacokinetic profiles of caffeic acid phenethyl ester (CAPE) and its catechol‐ring fluorinated derivative (FCAPE) were determined in rats after…”
Get full text
Journal Article -
11
Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model
Published in Pharmaceutical research (01-09-1997)“…The objective of this investigation was to determine, using the Caco-2 cell culture model, the extent to which the paracellular and transcellular routes…”
Get full text
Journal Article -
12
Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays
Published in American Journal of Physiology: Cell Physiology (01-11-2001)“…To assess the feasibility of using cDNA microarrays to understand the response of endothelial cells to lipopolysaccharide (LPS) and to evaluate potentially…”
Get more information
Journal Article -
13
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report
Published in Clinical therapeutics (01-09-2010)“…Abstract Background: Modified-release (MR) products are complex dosage forms designed to release drug in a controlled manner to achieve the desired efficacy…”
Get full text
Journal Article -
14
Reuse of cDNA microarrays hybridized with cRNA by stripping with RNase H
Published in BioTechniques (01-11-2008)“…DNA microarrays are powerful tools for global analysis of gene transcript expression. However, their high cost and the need for replication have limited their…”
Get full text
Journal Article -
15
Quantitative determination of fluorinated caffeic acid phenethyl ester derivative from rat blood plasma by liquid chromatography-electrospray ionization tandem mass spectrometry
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (01-05-2008)“…The quantitative determination of caffeic acid phenethyl ester (CAPE) and its fluorinated derivative (FCAPE) from rat plasma using ultra-performance liquid…”
Get full text
Journal Article -
16
Pharmacokinetics and biodistribution of a nucleotide-based thrombin inhibitor in rats
Published in Pharmaceutical research (01-06-1998)“…To characterize the pharmacokinetic and tissue distribution profiles of a nucleotide-based thrombin inhibitor (GS522, phosphodiester oligonucleotide,…”
Get full text
Journal Article -
17
Scientific Perspectives on Extending the Provision for Waivers of In vivo Bioavailability and Bioequivalence Studies for Drug Products Containing High Solubility-Low Permeability Drugs (BCS-Class 3)
Published in The AAPS journal (01-06-2008)“…Recently, there has been increased interest in extending the provision for waivers of in vivo bioavailability and bioequivalence (BA–BE) studies that appeared…”
Get full text
Journal Article -
18
Isothermal and nonisothermal decomposition of thymopentin and its analogs in aqueous solution
Published in Pharmaceutical research (01-11-1998)“…The degradation kinetics of thymopentin (RKDVY) and its analogs (RKDVW and RPDVY) in aqueous solution was studied by isothermal and nonisothermal methods. The…”
Get full text
Journal Article -
19
Dependence of cytotoxicity of menadione and cytoprotection by antioxidants in human endothelial cells on oxygen levels: Atmospheric oxygen versus physiological levels
Published in The FASEB journal (01-04-2013)“…Abstract only The goal of in vitro screens of potential cytoprotective agents is to identify drugs that will be beneficial in vivo. However, in vitro screens…”
Get full text
Journal Article -
20
Determination of the Minimum Exposure Time for Effecting Cytoprotection in Human Umbilical Vein Endothelial Cells (HUVEC) for Caffeic Acid Phenylethyl Ester (CAPE) and Amide (CAPA)
Published in The FASEB journal (01-04-2012)“…Abstract only We have previously shown that CAPE and CAPA protect HUVEC from oxidant stress. 1 This activity was correlated with the production of heme…”
Get full text
Journal Article